FR2973378B1 - Derives d'acide hydroxybisphosphonique bifonctionnels - Google Patents

Derives d'acide hydroxybisphosphonique bifonctionnels

Info

Publication number
FR2973378B1
FR2973378B1 FR1152546A FR1152546A FR2973378B1 FR 2973378 B1 FR2973378 B1 FR 2973378B1 FR 1152546 A FR1152546 A FR 1152546A FR 1152546 A FR1152546 A FR 1152546A FR 2973378 B1 FR2973378 B1 FR 2973378B1
Authority
FR
France
Prior art keywords
bifunctional
acid derivatives
hydroxybisphosphonic acid
hydroxybisphosphonic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1152546A
Other languages
English (en)
Other versions
FR2973378A1 (fr
Inventor
Maxim Egorov
Jean-Yves Goujon
Bot Ronan Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlanthera SAS
Original Assignee
Atlanthera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1152546A priority Critical patent/FR2973378B1/fr
Application filed by Atlanthera SAS filed Critical Atlanthera SAS
Priority to EP12711632.5A priority patent/EP2691402B1/fr
Priority to US14/008,986 priority patent/US9173946B2/en
Priority to ES12711632T priority patent/ES2743276T3/es
Priority to PCT/EP2012/055569 priority patent/WO2012130911A1/fr
Priority to JP2014501606A priority patent/JP6026499B2/ja
Priority to CA2831713A priority patent/CA2831713C/fr
Publication of FR2973378A1 publication Critical patent/FR2973378A1/fr
Application granted granted Critical
Publication of FR2973378B1 publication Critical patent/FR2973378B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548—Phosphates or phosphonates, e.g. bone-seeking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3869—Polyphosphonic acids containing carboxylic acid or carboxylic acid derivative substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
FR1152546A 2011-03-28 2011-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels Active FR2973378B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1152546A FR2973378B1 (fr) 2011-03-28 2011-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels
US14/008,986 US9173946B2 (en) 2011-03-28 2012-03-28 Bifunctional hydroxy-bisphosphonic acid derivatives
ES12711632T ES2743276T3 (es) 2011-03-28 2012-03-28 Derivados de ácido hidroxibisfosfónico bifuncionales
PCT/EP2012/055569 WO2012130911A1 (fr) 2011-03-28 2012-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels
EP12711632.5A EP2691402B1 (fr) 2011-03-28 2012-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels
JP2014501606A JP6026499B2 (ja) 2011-03-28 2012-03-28 二機能性ヒドロキシ−ビスホスホン酸誘導体
CA2831713A CA2831713C (fr) 2011-03-28 2012-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels et leur utilisation dans la vectorisation de molecules d'interet therapeutique ou diagnostique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1152546A FR2973378B1 (fr) 2011-03-28 2011-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels

Publications (2)

Publication Number Publication Date
FR2973378A1 FR2973378A1 (fr) 2012-10-05
FR2973378B1 true FR2973378B1 (fr) 2013-10-04

Family

ID=45926557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1152546A Active FR2973378B1 (fr) 2011-03-28 2011-03-28 Derives d'acide hydroxybisphosphonique bifonctionnels

Country Status (7)

Country Link
US (1) US9173946B2 (fr)
EP (1) EP2691402B1 (fr)
JP (1) JP6026499B2 (fr)
CA (1) CA2831713C (fr)
ES (1) ES2743276T3 (fr)
FR (1) FR2973378B1 (fr)
WO (1) WO2012130911A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3028762B1 (fr) * 2014-11-20 2017-01-06 Atlanthera Derives hydroxybisphosphoniques hydrosolubles de la doxorubicine
EP3085390B1 (fr) * 2015-04-20 2020-02-26 Taiwan Hopax Chems. Mfg. Co., Ltd. Composé pour exploration osseuse et son utilisation
US11679099B2 (en) * 2020-05-13 2023-06-20 Seoul National University R&Db Foundation Use of HIF-2α inhibitors for treating chondrosarcoma, or preventing recurrence and metastasis thereof
FR3122427A1 (fr) 2021-04-30 2022-11-04 Atlanthéra Derives hydroxybisphosphoniques de meloxicam pour traitement des maladies inflammatoires osteoarticulaires
WO2023107909A1 (fr) * 2021-12-10 2023-06-15 Ppg Industries Ohio, Inc. Composé à fonction carbazate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2558373A1 (de) 1974-12-26 1976-07-08 Yoshida Kogyo Kk Aussenfenstereinheit
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
EP1615639A2 (fr) * 2003-04-03 2006-01-18 Semafore Pharmaceuticals, Inc. Agents de protection cibles de la moelle osseuse
WO2007096703A2 (fr) * 2005-08-11 2007-08-30 Targanta Therapeutics Inc. Rifamycines phosphonatées et utilisation pour la prévention des infections des os et des articulations
US8133311B2 (en) * 2007-04-30 2012-03-13 Cabot Corporation Pigment dipsersions comprising functionalized non-polymeric dispersants
FR2926080B1 (fr) * 2008-01-03 2010-04-02 Univ Nantes Procede de synthese de derives d'acide hydroxy-bisphosphonique
FR2926081B1 (fr) 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
EP2289558A1 (fr) * 2009-08-25 2011-03-02 KTB Tumorforschungsgesellschaft mbH Promédicaments à base de bisphosphonate

Also Published As

Publication number Publication date
EP2691402B1 (fr) 2019-05-08
JP2014514288A (ja) 2014-06-19
JP6026499B2 (ja) 2016-11-16
CA2831713A1 (fr) 2012-10-04
US20140086843A1 (en) 2014-03-27
WO2012130911A1 (fr) 2012-10-04
FR2973378A1 (fr) 2012-10-05
ES2743276T3 (es) 2020-02-18
EP2691402A1 (fr) 2014-02-05
CA2831713C (fr) 2020-09-15
US9173946B2 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
SMT201500054B (it) 2-Anilinobenzimidazolo-6-carbossammidi come agentianti-infiammattori
BR112014006703A8 (pt) "pirrolobenzodiazepinas
DK2623507T3 (da) Morpholinonukleinsyrederivat
ES1114931Y (es) Juguete acuatico
BR302012001940S1 (pt) "configuração aplicada em para-choque dianteiro"
FR2971422B1 (fr) Granules d'acide gamma-hydroxybutyrique
BR302012001944S1 (pt) "configuração aplicada em espelho retrovisor"
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
CO6940426A2 (es) Formulaciones farmacéuticas
CO6960557A2 (es) Derivados de 2-yodo-imidazol
DK3498313T3 (da) Rørformede proteser
CO6920301A2 (es) Derivados insecticidas de 2-metoxibenzamida
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
FR2973378B1 (fr) Derives d'acide hydroxybisphosphonique bifonctionnels
BR302012001925S1 (pt) "configuração aplicada em calota"
DK2672817T3 (da) Forbedrede insekticide formuleringer
CO6852074A2 (es) Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
BR302012001178S1 (pt) "configuração aplicada em espelho retrovisor"
IT1398997B1 (it) Giostra per l'allenamento di cavalli
DK2854789T3 (da) Genotype- eller fænotype-baserede lægemiddelformuleringer
FR2971446B3 (fr) Coiff'rasoir
FR2990112B1 (fr) Support d'assise
ITBA20110009U1 (it) "bellexpo" espositore dinamico motorizzato
ES1073075Y (es) Banera infantil
BRDI7104595S (pt) " configuração aplicada em boneca"

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14